Related Experiment Video
Updated: Oct 4, 2025

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
Percutaneous tricuspid valve implantation: an alternative in critically ill patients
Alvaro Lafuente-Romero1, Enrique José Balbacid Domingo1, Cesar Abelleira Pardeiro1
1Servicio de Cardiología Pediátrica y Cardiopatías Congénitas, Hospital Universitario La Paz, Madrid, Spain.
Insights
Percutaneous tricuspid replacement offers a new treatment for complex congenital heart disease patients with tricuspid valve issues. This minimally invasive approach provides a viable option for those at high surgical risk.
Area of Science:
- Cardiology
- Interventional Cardiology
- Congenital Heart Disease
Background:
- Tricuspid valvulopathy is increasingly recognized, particularly with advancements in percutaneous interventions.
- Congenital heart malformations (CHD) can lead to primary or secondary tricuspid valve dysfunction.
- High surgical risk often precludes traditional interventions for these patients.
Purpose of the Study:
- To report the successful percutaneous tricuspid replacement in two adult patients with complex congenital heart malformations.
- To highlight the feasibility of minimally invasive tricuspid valve intervention in challenging clinical scenarios.
Main Methods:
- Case series presentation of two adult patients.
- Focus on percutaneous tricuspid valve replacement procedures.
- Management of complex congenital heart disease with borderline clinical status.
Main Results:
- Successful percutaneous tricuspid replacement was achieved in both cases.
- Patients were in borderline clinical situations, indicating a high-risk cohort.
- Demonstrated feasibility of the percutaneous approach for severe tricuspid valvulopathy in complex CHD.
Conclusions:
- Percutaneous tricuspid replacement is a safe and effective option for select adult patients with complex CHD and severe tricuspid valvulopathy.
- This approach expands treatment possibilities for patients previously deemed high surgical risk.
- Further research is warranted to establish long-term outcomes.
Abstract:
Tricuspid valvulopathy has gained a lot of attention in recent years, especially due to the advances in percutaneous management. CHD can present with primary or secondary malfunction of the tricuspid valve, often not addressed due to high surgical risk after several interventions. We present two cases of adults with complex congenital heart malformations and borderline clinical situations who successfully underwent percutaneous tricuspid replacement.
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Mitral Stenosis III: Medical Management
Cardiomyopathy V: Interprofessional Care

